Designing a smallpox B-cell and T-cell multi-epitope subunit vaccine using a comprehensive immunoinformatics approach

Area of Science:

• Immunology and Virology
• Bioinformatics and Vaccine Design

Background:

• Smallpox, caused by the variola virus, is a historically deadly disease and a potential bioweapon.
• Vaccines are crucial for preventing variola virus infection and spread.
• The variola virus remains a significant public health concern despite its eradication.

Purpose of the Study:

• To design a novel peptide vaccine against the variola virus using immunoinformatics tools.
• To create a vaccine capable of eliciting a robust immune response against smallpox.
• To provide a reference for designing vaccines against related viruses like monkeypox.

Main Methods:

• Utilized immunoinformatics tools to design a peptide vaccine from protective proteins of vaccinia WR strains.
• Screened for non-toxic, non-allergenic T-cell and B-cell epitopes, linking them with special linkers.
• Incorporated an adjuvant to enhance immunogenicity and analyzed vaccine-receptor binding and stability using 3D structure display, docking, and free energy calculations.

Main Results:

• The designed peptide vaccine demonstrated high binding affinity and stability with Toll-like receptor 3.
• In silico analysis indicated the vaccine's potential to induce effective and safe immune responses.
• The vaccine design integrates preventive measures to mitigate potential side effects.

Conclusions:

• A novel peptide vaccine against variola virus has been successfully designed using immunoinformatics.
• The designed vaccine holds promise for generating an effective and safe immune response against smallpox.
• This approach offers a valuable framework for developing vaccines against orthopoxviruses, including monkeypox.